Articles

Ocean Biomedical is popping higher on an encouraging development for its drug patent application, drawing interest toward OCEA stock. More

Twitter's advertising business is in trouble, and it seems to be getting worse. Here's why this could be bad news for Tesla stock. More

F stock doesn't yet reflect Ford's impressive sales results in the U.S. and ambitious plans for the European electric vehicle market. More

While it’s always difficult to determine which stocks to buy might break out imminently, speculators should watch these ideas. More

While investing in silver presents incredible risks due to wild volatility, the present juncture makes this arena quite attractive. More

Fears of a 2023 recession are mounting following the release of Fed documents suggesting a banking crisis-related slowdown is on the way. More

Although moving against the grain presents its own distinct set of risks, these short-squeeze stocks may profit the contrarian. More

Subscriber Sign in